DelSiTech And Bayer Partner To Develop Innovative Drug Delivery Technology For Ophthalmology

On the picture: CEO Lasse Leino, DelSiTech Ltd

DelSiTech Ltd, a Finnish drug delivery technology and drug development company, and Bayer have signed a Collaboration and Technology Licence Agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology. Read more.

DelSiTech Ltd., located in Turku, Finland, develops and commercializes its proprietary biodegradable silica based drug delivery technology. The Company collaborates with a number of pharma and biotech companies globally and works with its partners to turn their product ideas into novel drug products.

DelSiTech Ltd

ScanBalt Business Club